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Thioredoxin 1 (Trx1) facilitates the reduction of sig-
naling molecules and transcription factors by cyste-
ine thiol-disulfide exchange, thereby regulating cell
growth and death. Here we studied the molecular
mechanism by which Trx1 attenuates cardiac hyper-
trophy. Trx1 upregulates DnaJb5, a heat shock pro-
tein 40, and forms a multiple-protein complex with
DnaJb5 and class II histone deacetylases (HDACs),
master negative regulators of cardiac hypertrophy.
Both Cys-274/Cys-276 in DnaJb5 and Cys-667/Cys-
669 in HDAC4 are oxidized and form intramolecular
disulfide bonds in response to reactive oxygen spe-
cies (ROS)-generating hypertrophic stimuli, such as
phenylephrine, whereas they are reduced by Trx1.
Whereas reduction of Cys-274/Cys-276 in DnaJb5
is essential for interaction between DnaJb5 and
HDAC4, reduction of Cys-667/Cys-669 in HDAC4
inhibits its nuclear export, independently of its phos-
phorylation status. Our study reveals a novel regula-
tory mechanism of cardiac hypertrophy through
which the nucleocytoplasmic shuttling of class II
HDACs is modulated by their redox modification in
a Trx1-sensitive manner.
INTRODUCTION
Reduction and oxidation (redox) is an important mechanism of
posttranslational modification (Berndt et al., 2007). Reactive ox-
ygen species (ROS) produced from various sources, such as
mitochondrial leakage and NAD(P)H oxidases, oxidize signaling
molecules and transcription factors. Thiol groups (R-SH) of spe-
cific cysteine residues are often oxidized to sulfenic acids
(R-SOH) reversibly and to sulfinic (R-SO2
) or sulfonic
(R-SO3
2) acids irreversibly (Berndt et al., 2007). Sulfenic acids
further form intra- or intermolecular disulfide bonds (R-S-S-R)
or mixed disulfide bonds with glutathione (R-S-SG; glutathiony-
lation). Disulfide bonds and glutathionylation induce a conforma-
tional change in the molecule, thereby regulating enzymatic978 Cell 133, 978–993, June 13, 2008 ª2008 Elsevier Inc.activity, protein-protein interaction, and subcellular localization
(Berndt et al., 2007; Nakamura et al., 1997).
Cells have two kinds of system to counteract ROS. The first
group of molecules eliminates excess ROS directly; superoxide
dismutases convert superoxide to hydrogen peroxide (H2O2),
and catalases and peroxidases catalyze the production of water
from H2O2. The other group includes glutathione (Glu-Cys-Gly)
and thioredoxin (Trx), which reduce thiol groups of oxidized pro-
teins (Berndt et al., 2007). Trx1 is a 12 kD protein that regulates
signaling molecules and transcription factors and mediates
redox-regulated gene expression. During reduction of target
proteins, Trx1 is oxidized to form a disulfide bond between
the two cysteine residues at 32 and 35 in its catalytic core
(Figure S1 available online). The oxidized Trx1 is then reduced
and regenerated by thioredoxin reductase and NADPH. Trx1,
Trx reductase, and NADPH, collectively called the Trx system,
operate as a powerful protein disulfide reductase system (Berndt
et al., 2007; Nakamura et al., 1997).
Redox states critically affect the function of the heart. Both ox-
idative and reductive stress are involved in the pathogenesis of
cardiac hypertrophy and heart failure (Cave et al., 2006; Rajase-
karan et al., 2007). Cardiac hypertrophy, defined by the enlarge-
ment of ventricular mass, is initially adaptive against hemody-
namic overloads, such as high blood pressure. However, the
long-term presence of hypertrophy often leads to heart failure,
possibly because of increased cell death. ROS regulate signaling
molecules and transcription factors involved in hypertrophy and
cell death. At low levels (10–30 mM), H2O2, a cell-permeable
ROS, is associated with hypertrophy, but at higher levels, it is as-
sociated with apoptosis or necrosis in cardiac myocytes (Kwon
et al., 2003). ROS play an important role in mediating cardiac hy-
pertrophy stimulated by hemodynamic overload, as well as by
agonists for G protein-coupled receptors, such as phenylephrine
(PE) and angiotensin II (Hirotani et al., 2002). In contrast, ROS-
eliminating molecules, such as superoxide dismutases (Siwik
et al., 1999) and catalase (Li et al., 1997), play protective roles
in diseased hearts. Likewise, Trx1 attenuates heart cell death
after ischemia-reperfusion (Tao et al., 2004). Using transgenic
mice with cardiac-specific overexpression of Trx1 (Tg-Trx1) or
its dominant-negative form (Tg-DN-Trx1), we have demon-
strated previously that one of the prominent effects of Trx1 in
the heart is to inhibit hypertrophy (Yamamoto et al., 2003).
Gene expression is controlled in part by the acetylation and
deacetylation of histones, the latter of which is mediated by
a group of molecules called histone deacetylases (HDACs).
Among them, class II HDACs are expressed only in nonprolifer-
ative cells, including myocytes (Backs and Olson, 2006). Dy-
namic nucleocytoplasmic shuttling has been proposed as one
of the most fundamental mechanisms regulating the function
of class II HDACs (McKinsey et al., 2000). Phosphorylation of
class II HDACs at specific serine residues after hypertrophic
stimulation induces the interaction with 14-3-3 that leads to
masking of the nuclear localization signal (NLS) from importin
a and unmasking of the nuclear export signal (NES) to CRM1 (ex-
portin). The class II HDACs are thereby exported to the cytosol,
where they can no longer suppress target transcription factors.
In the heart, nuclear export of class II HDACs directly elicits ac-
tivation of nuclear factor of activated T cell (NFAT) and myocyte
enhancer factor 2 (MEF2), master positive regulators of cardiac
hypertrophy (Backs and Olson, 2006). Although class II HDACs
may be regulated by other forms of posttranslational modifi-
cation, such as sumoylation and ubiquitination, as well (Kirsh
et al., 2002; Potthoff et al., 2007), a redox-dependent mecha-
nism has not been demonstrated previously.
We here demonstrate that Trx1 regulates the nucleocytoplas-
mic shuttling of class II HDACs through a redox-dependent
mechanism. By forming a multiprotein complex with DnaJb5,
a heat shock protein 40, and TBP-2, a Trx1-binding protein,
Trx1 reduces HDAC4, a class II HDAC, at Cys-667 and Cys-
669, which are easily oxidized to form a disulfide bond in
response to hypertrophic stimuli. The redox status of these cys-
teines critically affects the localization of HDAC4, thereby regu-
lating cardiac hypertrophy. The molecular link between the
redox-regulating protein Trx1 and class II HDACs may provide
new insight into the mechanism by which redox regulates the
development of cardiac hypertrophy.
RESULTS
Trx1 Upregulates DnaJb5 in Mouse Hearts
and Cardiac Myocytes
In order to search for genes that are regulated by Trx1 in the heart
and suppress cardiac hypertrophy, we performed DNA microar-
ray analyses (Ago et al., 2006). We identifiedDnaJb5 as one of the
genes specifically upregulated in Tg-Trx1 but not in Tg-DN-Trx1
(Figure S2). Consistently, protein expression of DnaJb5 was up-
regulated in both Tg-Trx1 mice (Figure 1A) and Trx1-overex-
pressing myocytes (Figure 1B). Conversely, treatment with short
hairpin RNA (shRNA) against Trx1 (shTrx1) decreased the expres-
sion of DnaJb5 in myocytes (Figure 1C). Trx1 also upregulated
expression of Hsp70, albeit to a lesser extent (Figures 1A–1C).
Immunocytochemistry and immunoblot analyses showed that
both Trx1 and DnaJb5 are localized in both the nucleus and cyto-
sol in cultured myocytes under serum-free conditions (Figures 1D
and 1E), as well as in mouse hearts at baseline (Figure 1E).
DnaJb5 Associates with Trx1 through Interaction with
TBP-2 and Enhances the Activity of Trx1
We examined the possibility that Trx1 interacts with DnaJb5.
Pull-down assays revealed that although DnaJb5 did not bindto Trx1 directly (Figure 1F, left), it strongly interacted with TBP-2
(Figure 1F, right). Physical interaction between endogenous
DnaJb5 and TBP-2 in cardiac myocytes was confirmed in the
presence or absence of a hypertrophic stimulus, such as PE
(Figure 1G and Figure S3).
We next examined whether DnaJb5 affects the interaction
between Trx1 and TBP-2. Pull-down assays showed that TBP-
2 interacts with HA-Trx1 in COS7 cells. When HA-DnaJb5 was
overexpressed together with HA-Trx1, it did not interfere with
the interaction between Trx1 and TBP-2, suggesting that
DnaJb5 can form a complex with Trx1 and TBP-2 (Figure S4).
Because TBP-2 was originally reported to be an inhibitor of
Trx1 (Nishiyama et al., 1999), we examined whether DnaJb5 af-
fects the reducing activity of Trx1 in the complex. Consistent with
the previous report, TBP-2 significantly suppressed the reducing
activity of Trx1 when TBP-2 was co-overexpressed with Trx1 in
COS7 cells (Figure 1H). However, when DnaJb5 was co-overex-
pressed together with Trx1 and TBP-2, the reducing activity of
Trx1 was significantly restored (Figure 1H).
TBP-2 Mediates Nuclear Localization
of Trx1 and DnaJb5
Because TBP-2 interacts with importin a1, a component of the
nuclear import machinery (Nishinaka et al., 2004), we hypothe-
sized that TBP-2 mediates the nuclear localization of Trx1 and
DnaJb5. Immunoblot analyses showed that shRNA against
TBP-2 (shTBP-2) significantly decreased Trx1 and DnaJb5 levels
in the nucleus and increased them in the cytosol of cardiac
myocytes (Figure 1I). These findings suggest that TBP-2 medi-
ates the nuclear localization of Trx1 and DnaJb5.
Trx1 and DnaJb5 Suppress PE-Induced NFAT
Activation and Cardiac Hypertrophy
To explain the antihypertrophic effect of Trx1, we hypothesized
that Trx1 and DnaJb5 suppress the activity of key transcription
factors that lead to cardiac hypertrophy, such as NFAT (Molken-
tin et al., 1998). Treatment with PE (Figure 2A) or overexpression
of catalytically active calcineurin (Figure S5) increased the activ-
ity of NFAT, as determined by reporter gene assays in myocytes.
Overexpression of Trx1, DnaJb5, or TBP-2 significantly sup-
pressed both PE- and calcineurin-induced activation of NFAT
(Figure 2A and Figure S5). The suppressive effect of Trx1 on
the NFAT activity was completely abolished when either shRNA
of DnaJb5 (shDnaJb5) or shTBP-2 was cotransfected with Trx1
(Figure 2A). We also examined the effect of Trx1, DnaJb5, or
TBP-2 on expression of atrial natriuretic factor (ANF), a target
gene of NFAT (Molkentin et al., 1998), and cardiac hypertrophy
in response to PE. Trx1, DnaJb5, and TBP-2 suppressed the
PE-induced increases in ANF expression, cell size, and protein
content, whereas knockdown of either DnaJb5 or TBP-2 attenu-
ated the Trx1-mediated suppression of these parameters (Fig-
ures 2B and 2C). These findings suggest that overexpression
of either Trx1, DnaJb5 or TBP-2 suppresses PE-induced cardiac
hypertrophy and that both DnaJb5 and TBP-2 are required for
Trx1-induced suppression of cardiac hypertrophy.
To confirm the suppressive effect of Trx1 on NFAT activity
in vivo, we made bitransgenic mice harboring both a Trx1 trans-
gene and NFAT-reporter gene. Infusion of PE into NFAT-reporterCell 133, 978–993, June 13, 2008 ª2008 Elsevier Inc. 979
Figure 1. Trx1 Upregulates DnaJb5 and Forms a Complex with DnaJb5 via TBP-2
(A–C) Expression of Trx1, DnaJb5, Hsp70, and actin was examined by immunoblot, through the use of NTg and Tg-Trx1 heart homogenates (A) or myocytes
transduced with the indicated adenovirus (B and C).
(D) Myocytes cultured under serum-free conditions were stained with a Trx1 or DnaJb5 antibody (red), an actinin antibody (green), and DAPI (blue).
(E) Expression of Trx1 and DnaJb5 was examined by immunoblot, through the use of cytosolic and nuclear fractions of cultured myocytes or mouse hearts.
(F) Interaction between Trx1 and DnaJb5 (left) or between TBP-2 and DnaJb5 (right) was examined by pull-down assays with the indicated recombinant proteins.980 Cell 133, 978–993, June 13, 2008 ª2008 Elsevier Inc.
mice without Trx1 overexpression increased the activity of NFAT
in the heart and induced cardiac hypertrophy (Figure 2D), both of
which were attenuated in Trx1 overexpression mice (Figure 2D).
These findings indicate that Trx1 suppresses PE-induced NFAT
activation and cardiac hypertrophy in vivo as well as in vitro.
DnaJb5 Directly Binds to the HDAC Domain
of Class II HDACs
Class II HDACs inhibit the activity of key transcription factors me-
diating cardiac hypertrophy, such as NFAT and MEF2 (Backs
and Olson, 2006). A variant form of Mrj (DnaJb6), another DnaJ
family protein, interacts with HDAC4 (Dai et al., 2005). We there-
fore hypothesized that DnaJb5 upregulated by Trx1 recruits
class II HDACs into the nucleus and suppresses cardiac hyper-
trophy.
Coimmunoprecipitation assays showed that DnaJb5 interacts
physically with HDAC4 in myocytes (Figure 3A). The primary
structure of the HDAC domain is conserved among all class II
HDACs. The HDAC domain of HDAC4 alone was sufficient for
interaction with DnaJb5, whereas even full-length HDAC4 did
not interact with DnaJb1, another DnaJ protein (Figure 3B). In
addition, the HDAC domain of HDAC5, another class II HDAC,
also interacted with DnaJb5 (Figure S6). Truncated mutants of
the HDAC domain, HDAC4 (628–971) and HDAC4 (628–881),
were able to interact with DnaJb5 (Figure 3C). However, our
attempt at making the further truncated HDAC4 (628–768)
resulted in an insoluble protein, leaving HDAC4 (628–881) as
the minimum DnaJb5 interaction domain identified. A HDAC4
mutant in which residues 628–881 are deleted (HDAC4D628–
881) failed to interact with DnaJb5 (Figure 3D). Interestingly,
HDAC4D628–881 was localized in the cytosol (Figure 3D). These
findings suggest that a part of the HDAC domain (628–881) is ne-
cessary for the HDAC4-DnaJb5 interaction and determines the
subcellular localization of HDAC4. As for DnaJb5, pull-down
assays showed that the C-terminal region of DnaJb5 (residues
71–348) is necessary and sufficient for the interaction with
HDAC4 (Figure 3E).
The Redox State of DnaJb5, Regulated by Trx1, Affects
Its Interaction with HDAC4 and HDAC4 Localization
To test the possibility that the interaction between DnaJb5 and
HDAC4 is regulated by redox, we examined the effect of H2O2
on the interaction. Treatment with H2O2 did not affect the stability
of either DnaJb5 or HDAC4 (Figure 4A). However, the interaction
between DnaJb5 and HDAC4 was significantly attenuated by
H2O2 in a dose-dependent manner (Figure 4A). Thus, we exam-
ined whether DnaJb5 is modified by redox, using mass spec-
trometry (MS) analysis. The MS/MS spectra showed that, under
oxidizing conditions, Cys-274 and Cys-276 in DnaJb5 readily
form a disulfide bond (Figure 4B1) which was reduced by tris(2-carboxyethyl) phosphine (TCEP), a reducing reagent (Fig-
ure 4B2). To test whether Trx1 reduces these cysteines, we
performed a Trx1 reduction assay. The MS showed that Trx1 sig-
nificantly reduced the oxidized peptide of DnaJb5 (residues
271–286) (Figure 4C2) compared to buffer alone and DN-Trx1
(Figures 4C1 and 4C3).
For further confirmation that Cys-274 and Cys-276 in DnaJb5
are oxidized to form a disulfide bond in situ, HA-DnaJb5 immu-
noprecipitated from myocyte lysates treated with iodoacetamide
(IAM), a reagent which covalently binds to the thiol group of
reactive cysteines in their reduced forms, was subjected to MS
analyses. DnaJb5 exists predominantly as an IAM-labeled re-
duced form (m/z 1775.84) under serum-free conditions (Figures
4D1, 4D4, and 4D6). In response to PE treatment, a peptide con-
taining a disulfide bond between Cys-274 and Cys-276 (m/z
1659.79) (Figure 4D5) increased significantly, whereas the mass
of IAM-labeled peptide was decreased (Figures 4D2 and 4D4).
The increased disulfide bond formation reverted to control levels
when Trx1 was coexpressed (Figures 4D3 and 4D4). These re-
sults suggest that Cys-274 and Cys-276 in DnaJb5 are oxidized
in response to hypertrophic stimuli and reduced by Trx1 in car-
diac myocytes.
We further examined the role of Cys-274 and Cys-276 in me-
diating the interaction between DnaJb5 and HDAC4. Treatment
of cardiac myocytes with PE attenuated the interaction between
both endogenous and overexpressed DnaJb5 and HDAC4
(Figure 4E and Figure S3). The DnaJb5 C274/276S mutant failed
to interact with HDAC4 even in the absence of PE (Figure 4E),
suggesting that intact cysteines are required for the interaction.
The interaction was also attenuated by ethylene diamine tetra-
acetic acid (EDTA) and enhanced by zinc chloride (Figure 4F),
suggesting that Cys-274 and Cys-276 in DnaJb5 participate in
zinc coordination and that disruption of the zinc-thiol interaction
inhibits the interaction between DnaJb5 and HDAC4. On the
other hand, the DnaJb5 C274/276S mutant was able to interact
with TBP-2, suggesting that the interaction between DnaJb5 and
TBP-2 is not regulated by modification of Cys-274/Cys-276
(Figure S7).
We further examined the effect of the DnaJb5 C274/276S mu-
tant on the localization of HDAC4. When the DnaJb5 C274/276S
mutant was overexpressed in myocytes, the nuclear localization
of HDAC4 was significantly attenuated (Figure 4G). Consistently,
the C274/276S substitution abolished the suppressive effect
of DnaJb5 on NFAT activity in myocytes stimulated with PE
(Figure 4H).
Trx1 Suppresses Nuclear Export of HDAC4
Induced by PE
Because HDAC4 has multiple cysteine residues in its HDAC do-
main, we tested the possibility that Trx1 reduces HDAC4 and(G) Coimmunoprecipitation assays with myocyte lysates. After immunoprecipitation with control IgG or a DnaJb5 antibody, immunoblots for endogenous DnaJb5
and TBP-2 were performed. Immunoblots of input controls (5% lysates) are also shown.
(H) Through the use of lysates of COS7 cells transfected with the indicated vectors, Trx-reducing activity was examined. Expression of the indicated proteins was
examined by immunoblot and analyzed densitometrically. Error bars indicate standard errors (n = 6, *p < 0.05).
(I) Effects of shTBP-2 on the localization of Trx1 and DnaJb5 were examined by immunoblot. Seventy-two hours after treatment with either LacZ or shTBP-2,
the cytosolic and nuclear fractions were prepared from myocytes. The percentage of total Trx1 or DnaJb5 in each compartment was obtained by densitometric
analyses. Error bars indicate standard errors (n = 4, *p < 0.05).Cell 133, 978–993, June 13, 2008 ª2008 Elsevier Inc. 981
Figure 2. Trx1 and DnaJb5 Inhibit PE-Induced NFAT Activation and Cardiac Hypertrophy
(A) Myocytes were transfected with the indicated vectors and an NFAT-luciferase reporter vector (n = 15, *p < 0.05). Error bars indicate standard errors.
(B) The effects of the indicated adenoviruses on ANF expression were examined by quantitative RT-PCR. ANF expression was normalized by 18S rRNA. Error
bars indicate standard errors (n = 5, *p < 0.05). Expression of the indicated molecules was determined by RT-PCR.
(C) Relative protein content and cell surface area of myocytes treated with the indicated adenoviruses in the presence or absence of PE for 72 hr were examined.
Error bars indicate standard errors (n = 6, *p < 0.05). Expression levels of the indicated proteins were examined by immunoblots.982 Cell 133, 978–993, June 13, 2008 ª2008 Elsevier Inc.
affects its localization. As reported (Backs and Olson, 2006),
HDAC4 was exported from the nucleus to the cytosol in myo-
cytes in response to PE (Figure 5A). However, the nuclear export
was drastically suppressed by overexpression of Trx1 but not
DN-Trx1 (Figure 5A). Because Trx1 did not affect the PE-induced
phosphorylation state of HDAC4, Trx1 may regulate the localiza-
tion of HDAC4 independently of phosphorylation (Figure 5B).
Identification of Redox-Sensitive Cysteines in HDAC4
We next sought to identify redox-sensitive cysteines in HDAC4
by using MS analysis. We used GST-HDAC domain of
HDAC4 (residues 628–1040) because 11 of the 14 cysteines in
HDAC4 are located in this region. Among these, nine cysteines
were detected in the MS analysis after trypsin or glutamic C en-
dopeptidase (Glu-C) digestion, whereas two cysteines (Cys-700
and Cys-1030) were not because the mass signal of peptides
containing these two cysteines was buried in the matrix back-
ground. Among the nine cysteines, Cys-667 and Cys-669
(Figure 5C) and Cys-982 and Cys-988 (Figure S8) formed disul-
fide bonds under oxidizing conditions that were reduced by
TCEP, whereas the other five (Cys-698, Cys-751, Cys-777,
Cys-813, and Cys-952) were found in a reduced form and were
unaffected by up to 250 mM H2O2 treatment. The four redox-
modifiable cysteines are conserved in class II HDACs. Impor-
tantly, Cys-667 and Cys-669 are located in the loop region,
which is not present in other classes of HDAC (Figure 5D). The
disulfide bond between Cys-982 and Cys-988 may form only in
a digested peptide because, based on the ternary-structured
model, Cys-982 and Cys-988 may be too far apart to form a disul-
fide bond in an a helix stretch (Vannini et al., 2004). MS showed
that Trx1 significantly reduced the oxidized peptide of HDAC4
(residues 665–681) (Figure 5E2) compared to buffer alone and
DN-Trx1 (Figures 5E1 and 5E3). Consistently, Trx1 failed to re-
duce the HDAC domain having the C667/669S substitution
(Figure S9), supporting the notion that Trx1 specifically reduces
Cys-667 and Cys-669 in HDAC4.
Significance of the Redox-Sensitive Cysteines,
Cys-667 and Cys-669, in HDAC4
We examined whether HDAC4 is oxidized in myocytes in re-
sponse to hypertrophic stimulation. The extent of cysteine re-
duction in HDAC4 was determined with biotinylated IAM.
When myocytes were treated with PE, levels of free thiol in
HDAC4 were significantly decreased within 5 min (Figure 6A).
Reduced cysteines were hardly detected in the HDAC4 C667/
669S mutant at baseline. These results suggest that Cys-667
and Cys-669 are major reactive thiols that are rapidly oxidized
in response to PE (Figure 6A). Overexpression of Trx1, but not
of DN-Trx1, attenuated the PE-induced oxidation of HDAC4
(Figure 6A). Importantly, the time course of oxidation was faster
than that of the PE-induced phosphorylation, which occurred
gradually after 60 min treatment with PE (Figure 6A). Immunos-
taining showed that nuclear export of HDAC4 started occurring
within 5 min after PE treatment (Figure 6B), suggesting that oxi-dation may initiate nuclear export of HDAC4 independently of
phosphorylation.
To elucidate the functional roles of cysteine modification at
Cys-667 and Cys-669 in HDAC4, we examined the localization
of the HDAC4 C667/669S and C667/669A mutants in myocytes.
In contrast to the localization of wild-type HDAC4, both of the
HDAC4 mutants were localized exclusively in the cytosol, even
without PE treatment (Figure 6C). The nuclear export of the mu-
tants was completely suppressed by 10 nM leptomycin B (LMB),
a specific inhibitor of CRM1 (exportin) (Figure 6C), suggesting
that the HDAC4 mutants are exported to the cytosol in
a CRM1-dependent manner. When wild-type HDAC4 was
transfected into myocytes, NFAT activity was significantly sup-
pressed (Figure 6D). Both the C667/669S and the C667/669A
mutants significantly enhanced NFAT activity in the absence of
PE and failed to inhibit PE-induced increases in NFAT activity
(Figure 6D). These results suggest that the intact cysteines are
required for the nuclear localization of HDAC4.
To test the effect of the C667/669S substitution on cardiac
hypertrophy in vivo, we attempted to generate transgenic mice
with cardiac-specific overexpression of wild-type HDAC4 (Tg-
HDAC4), as well as the C667/669S mutant (Tg-HDAC4 C667/
669S). We established four independent lines of Tg-HDAC4
C667/669S and used two lines, #21 and #40, for further analyses
(Figure 6E). In contrast, although we obtained three founders of
Tg-HDAC4, the founders either died prematurely or lacked
germline transmission. Compared to NTg, Tg-HDAC4 C667/
669S displayed significantly greater left ventricular (LV)
weight:body weight at 2–3 months of age at baseline
(Figure 6E). The cross-sectional area of LV myocytes was signif-
icantly greater in Tg-HDAC4 C667/669S than in NTg (Figures 6E
and 6F). Consistently, the mRNA level of the cardiac hypertrophy
marker gene, Anf, was significantly higher in Tg-HDAC4 C667/
669S (Figure 6E). The HDAC4 C667/669S mutant was localized
primarily in the cytosol in mouse hearts (Figure 6G), suggesting
that the HDAC4 C667/669S mutant is exported to the cytosol
and disrupts the suppressive effect of HDAC4 on cardiac hyper-
trophy in vivo.
The HDAC4 C667/669S mutant was able to interact with
DnaJb5 to almost the same extent as wild-type HDAC4 in pull-
down assays and in immunoprecipitation assays in myocytes
(Figures 6H and 6I), suggesting that the HDAC4 C667/669S
mutant can act as a dominant negative, possibly through com-
petition with endogenous HDAC4 for association with the
DnaJb5-TBP-2-Trx1 complex.
Because the HDAC4 mutant is exported to the cytosol in
a CRM1-dependent manner (Figure 6C), we hypothesized that
the HDAC domain may physically interact with the NES in
a redox-dependent fashion, thereby suppressing exposure of
the NES to CRM1. Pull-down assays revealed that the HDAC
domain can interact with the NES (residues 1040–1084 in
HDAC4) (Figure 6J). Interestingly, the interaction was attenuated
by the C667/669S substitution (Figure 6J). The intramolecular in-
teraction was also attenuated by H2O2 and EDTA, whereas it was(D) Mice with the NFAT-reporter gene alone or mice with overexpressed Trx1 and the reporter gene were treated with either PBS or PE (75 mg/kg/day) for 14 days
(n = 6 in each group). Cardiac hypertrophy was evaluated by LVW/BW (mg/g) (*p < 0.05). NFAT activity was measured by luciferase activity with heart homog-
enates (*p < 0.05). Error bars indicate standard errors. Expression levels of the indicated proteins were examined by immunoblots.Cell 133, 978–993, June 13, 2008 ª2008 Elsevier Inc. 983
Figure 3. DnaJb5 Interacts with HDAC4
(A) Myocyte lysates were used for immunoprecipitation with either control IgG or a DnaJb5 antibody. Immunoblots for DnaJb5 and HDAC4 were performed.
Immunoblots of input controls (5% lysates) are also shown.
(B) Lysates of COS7 cells transfected with myc-HDAC4 full-length (FL) or myc-HDAC domain of HDAC4 (628–1040) were used for pull-down assays with the
indicated MBP proteins.
(C) The indicated GST-fused truncated mutants of HDAC4 were incubated with MBP-DnaJb5 for pull-down assays.
(D) Localization of myc-tagged full-length HDAC4 and HDAC4 D628-881 was examined in COS7 cells. Cells were stained with a myc antibody (green) and DAPI
(blue) (left). Lysates of COS7 cells transfected with the indicated vectors were used for pull-down assays with MBP-DnaJb5. Expression of the myc-proteins was
examined by immunoblot (right).
(E) The indicated MBP proteins were incubated with GST-HDAC domain for pull-down assays.984 Cell 133, 978–993, June 13, 2008 ª2008 Elsevier Inc.
Figure 4. Redox-Regulated Interaction between DnaJb5 and HDAC4
(A) COS7 lysates with HDAC4 overexpression and MBP-DnaJb5 were treated with the indicated concentrations of H2O2 for 30 min and subjected to pull-down
assays. Statistical analysis of densitometric measurements is shown. Error bars indicate standard errors (n = 3, *p < 0.05).Cell 133, 978–993, June 13, 2008 ª2008 Elsevier Inc. 985
enhanced in the presence of zinc (Figure 6J). We speculate that
Cys-667 and Cys-669 in HDAC4 are involved in zinc coordination
and that the presence of the zinc-thiol structure promotes the in-
teraction between the HDAC domain and the NES. Although the
HDAC domain could mask the NES through intramolecular inter-
action under resting conditions, oxidative modification of the
cysteines after hypertrophic stimulation may disrupt this interac-
tion and unmask the NES to CRM1, thereby inducing the nuclear
export of HDAC4 (Figure 6K).
Does Redox Override Phosphorylation-Regulated
Localization of Class II HDACs?
To test the possibility that redox-mediated regulation of HDAC4
overrides phosphorylation-dependent nuclear export, we made
a mutant protein in which the three critical serines (at Ser-246,
Ser-467, and Ser-632) phosphorylated in response to hypertro-
phic stimulation were substituted with alanines (3SA), as well
as a mutant having both the 3SA and C667/669S substitutions
(3SA/C667/669S). Although the 3SA mutant was localized in
the nucleus in the resting state, it was exported to the cytosol
to some extent in response to PE (Figure 7A). In contrast, the
3SA/C667/669S mutant was localized in the cytosol, even in
the absence of hypertrophic stimuli (Figure 7A), indicating that
redox modification of HDAC4 at Cys-667 and Cys-669 can direct
nuclear export of HDAC4 even in the absence of phosphoryla-
tion. The suppression of NFAT activity by the 3SA mutant was
also abolished by the addition of the C667/669S substitution
(Figure 7B). Consistently, the cell size of myocytes overexpress-
ing the 3SA/C667/669S mutant was significantly greater than
that of those overexpressing the 3SA mutant (Figure 7C). To con-
firm these effects in vivo, we transduced adenoviruses harboring
the HDAC4 mutants into rat hearts. HDAC4 3SA/C667/669S was
localized mainly in the cytosol, in contrast with 3SA, which was
localized primarily in the nucleus (Figure 7D). In addition, we in-
jected plasmids harboring either HDAC4 3SA or 3SA/C667/
669S together with an ANF-luciferase vector directly into rat
hearts. ANF-luciferase activity was greater in rat hearts injected
with 3SA/C667/669S than in those with 3SA or vector alone
(Figure 7E), supporting the notion that the redox-modification
can induce nuclear export of HDAC4 even in the absence of
phosphorylation-mediated mechanisms in vivo.
We also made a mutant in which the three serines were
substituted with aspartates (3SD), a phosphorylation-mimicking986 Cell 133, 978–993, June 13, 2008 ª2008 Elsevier Inc.form, and examined its localization and activity. The 3SD mutant
was localized in the cytosol and enhanced the activity of NFAT
without treatment with PE (Figures 7A and 7B). However, coex-
pression of Trx1 attenuated the effect of 3SD on nuclear export
of HDAC4 and NFAT activation (Figures 7A and 7B). Taken
together, these results suggest that redox modification of
HDAC4 by Trx1 may be an independent mechanism determining
the localization of HDAC4, and it could potentially override the
phosphorylation-regulated mechanisms.
DISCUSSION
We demonstrate that Trx1 regulates disulfide bond formation
between two cysteine residues located in the HDAC domain
of class II HDACs through formation of a multiprotein complex
including class II HDACs and DnaJb5. The cysteine residues
of HDAC4 are oxidized by hypertrophic stimuli, and mutation
of these cysteines was sufficient to induce cardiac hypertrophy
in vivo. These results suggest that redox regulation of cysteines
by Trx1 is a powerful posttranslational mechanism regulating
subcellular localization of class II HDACs and cardiac muscle
growth.
DnaJb5 Links Trx1 and Class II HDACs, Both
Constitutive Negative Regulators of Cardiac
Hypertrophy
Our results suggest that DnaJb5 serves to connect Trx1 and
class II HDACs, important negative regulators of cardiac hyper-
trophy (Backs and Olson, 2006; Yamamoto et al., 2003). DnaJ
family proteins interact with Hsp70 and function as cochaper-
ones for the ATPase activity of Hsp70 (Qiu et al., 2006). DnaJ
proteins play a crucial role in recognizing specific targets, re-
cruiting them to Hsp70, and translocating folded proteins to
the proper intracellular organelle, such as the nucleus and mito-
chondria (Qiu et al., 2006). We speculate that DnaJb5 mediates
correct folding and nuclear localization of HDAC4 in the heart.
Is DnaJb5 a Redox-Regulated Chaperone?
A shorter variant of Mrj (DnaJb6) interacts with HDAC4 (Dai et al.,
2005). Importantly, however, the shorter form of Mrj contains no
cysteines. In contrast, DnaJb5 contains two critical cysteines in
its C-terminal region that regulate redox-dependent interaction
with HDAC4. Redox-dependent changes in chaperone activity(B) The MS/MS spectrum of a peptide [271–286] from recombinant GST-DnaJb5 treated with trypsin in vitro. The peptide under nonreducing conditions
(m/z 1659.79) contained a disulfide bond between Cys-274 and Cys-276 (1). Reduction of the peptide by TCEP produced a mass of 1661.79 due to reduction
of the two cysteines (2).
(C) MS spectra of DnaJb5 peptide [271–286] incubated with either the reaction buffer alone (1), Trx1 (2), or DN-Trx1 (3). Trx1 decreased the oxidized peptide
(m/z 1659.79) and increased the reduced peptide (m/z 1661.79) (2), compared to buffer alone (1) and DN-Trx1 (3).
(D) Myocytes transduced with HA-tagged DnaJb5 were treated with 100 mM PE for 4 hr in the presence or absence of Trx1 overexpression. Lysates were pre-
pared in the presence of 200 mM IAM. HA antibody immunoprecipitates were used for MS analyses. MS at baseline (1), after PE treatment (2), and after PE treat-
ment in the presence of Trx1 (3) are shown. A ratio of the peak height of the oxidized peptide (m/z 1659.79) to the total peptide including both the oxidized and
IAM-labeled reduced peptide (m/z 1775.84) is shown (4). MS/MS confirms that the m/z 1659.79 peptide includes a disulfide bond between Cys-274 and Cys-276
(5), and the m/z 1775.84 peptide includes IAM-alkylated cysteines (6).
(E) Effects of PE treatment on the interaction between wild-type DnaJb5 (WT) and HDAC4 or between DnaJb5 CS mutant (CS) and HDAC4 were examined in
myocytes overexpressing HDAC4 and DnaJb5 by immunoprecipitation assays. Immunoblots of control lysates are also shown.
(F) Effects of zinc and EDTA on the interaction between DnaJb5 and HDAC4 were examined by pull-down assays.
(G) Effects of overexpression of wild-type DnaJb5 or the C274/276S mutant on the localization of HDAC4. Myocytes were stained with a myc antibody (green),
a troponin I antibody (red), and DAPI (blue).
(H) Effects of the DnaJb5 C274/276S mutant on NFAT activity were examined in myocytes. Error bars indicate standard errors (n = 9, *p < 0.05).
Figure 5. Trx1 Reduces Cysteine Residues at 667 and 669 in HDAC4
(A) The indicated vectors were transfected into myocytes. After treatment with PE (100 mM) or vehicle for 4 hr, myocytes were stained with a myc antibody (green),
a troponin I antibody (red), and DAPI (blue).
(B) Myocytes were transduced with HDAC4 and either LacZ or Trx1 adenoviruses. Four hours after treatment with 100 mM PE or vehicle, expression and phos-
phorylation (at Ser-632) of HDAC4 were examined.
(C) The MS/MS spectrum of a tryptic peptide of HDAC4 [665–681]. The peptide under nonreducing conditions (m/z 1846.73) contained a disulfide bond between
Cys-667 and Cys-669 (1). Reduction of the peptide by TCEP produced a peptide mass of 1848.73 in which the two cysteines were reduced (2).
(D) Alignment of HDAC domains (amino acids 650–712 in HDAC4) among class II HDACs is shown. Red-colored amino acids are conserved. The positions of
conserved cysteine residues corresponding to Cys-667 and Cys-669 in HDAC4 are indicated by a blue rectangle. Predicted secondary structure is shown above
the alignment.
(E) MS spectra of HDAC4 peptide [665–681] incubated with either the reaction buffer alone (1), Trx1 (2) or DN-Trx1 (3). Trx1 decreased the oxidized peptide
(m/z 1846.73) and increased the reduced peptide (m/z 1848.73) (2), compared to buffer alone (1) and DN-Trx1(3).Cell 133, 978–993, June 13, 2008 ª2008 Elsevier Inc. 987
Figure 6. Significance of Cysteines at 667 and 669 in HDAC4
(A) Myocytes transduced with the indicated adenoviruses were treated with PE for the indicated time periods. The extent of reduced cysteines in HDAC4 was
detected. Expression and phosphorylation of HDAC4 was examined by immunoblot.
(B) Time-dependent nuclear export of HDAC4 after PE treatment is shown. Cells were stained with an HDAC4 antibody (green), an actinin antibody (red), and DAPI
(blue).
(C) After transduction with the indicated adenoviruses, myocytes were treated with 100 mM PE for 4 hr with or without 10 nM leptomycin B (LMB). Cells were
stained with an HDAC4 antibody (green), an actinin antibody (red), and DAPI (blue). Protein expression of the mutants is also shown.988 Cell 133, 978–993, June 13, 2008 ª2008 Elsevier Inc.
(D) The effect of the C667/669S or C667/669A substitution on NFAT activity was examined by an NFAT-reporter gene assay in the presence or absence of PE.
Error bars indicate standard errors (n = 12, *p < 0.05).
(E) Expression of HDAC4 protein and mRNA in NTg and Tg-HDAC4 C667/669S is shown. Heart size was determined as LVW/BW at 2–3 months of age (n = 10,
*p < 0.05). Average cross-sectional area of LV in NTg and Tg-HDAC4 C667/669 is shown (n = 5, *p < 0.05). mRNA level of ANF in NTg and Tg-HDAC4 C667/669S
was determined by qPCR (n = 10, *p < 0.05). Error bars indicate standard errors.
(F) Representative WGA staining of NTg and Tg-HDAC4 C667/669S.
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have been shown in other DnaJ proteins as well. DnaJa1 con-
tains zinc finger motifs (Cys-x-x-Cys), which coordinate zinc
and participate in protein-protein interaction (Choi et al., 2006).
DnaJa1 interacts with Trx1, which, in turn, reduces the cysteine
residues in the zinc fingers, thereby preserving its chaperone ac-
tivity (Choi et al., 2006). Although the two reactive cysteines in
DnaJb5 do not constitute a typical zinc finger motif, they may
participate in zinc coordination because the interaction between
DnaJb5 and HDAC4 is enhanced by zinc but attenuated by
EDTA. Oxidation or the C274/276S substitution in DnaJb5 may
attenuate zinc coordination, thereby suppressing the interaction
with HDAC4.
Furthermore, a close relationship between Trx1 and DnaJ pro-
teins has been reported. DnaJb4 interacts with TBP-2 in a yeast
two-hybrid system (Nishinaka et al., 2004). Some group C DnaJs
contain domains resembling Trx1 (Qiu et al., 2006). Surprisingly,
E. coli DnaJ itself harbors Trx-like reductase activity (Tang and
Wang, 2001). Thus, some, if not all, DnaJ members have re-
dox-regulated functions. Trx1 may regulate the interaction
between DnaJb5 and HDAC4, possibly through redox modifica-
tion of DnaJb5, whereas DnaJb5 maintains the reductase activ-
ity of Trx1 despite the presence of TBP-2, suggesting that Trx1
and DnaJb5 assist one another in performing their respective
functions.
How Do Trx1 and DnaJb5 Contribute to the Nuclear
Localization of HDAC4?
The nuclear localization of HDAC4 is regulated by previously un-
recognized mechanisms involving posttranslational oxidative
modification of cysteine residues in DnaJb5 and HDAC4. First,
the redox state of DnaJb5 may affect the nuclear localization of
HDAC4 through direct interaction with HDAC4 because overex-
pression of the DnaJb5 C274/276S mutant, which cannot inter-
act with HDAC4, attenuates the nuclear localization of HDAC4.
Second, the redox state of HDAC4 itself also affects its local-
ization. In the nonoxidizing state, the HDAC domain may associ-
ate with the NES via an intramolecular interaction and block ex-
posure of the NES to CRM1, thereby suppressing the nuclear
export of HDAC4. After oxidative modification of Cys-667 and
Cys-669, the HDAC domain may dissociate from the NES, which
is then exposed to CRM1, thereby inducing the nuclear export of
HDAC4. Trx1 may strengthen the interaction between the HDAC
domain and the NES, thereby preventing the nuclear export of
HDAC4. Because the ultrastructure of the HDAC4 C-terminal
end has not been solved, this model awaits confirmation by crys-
tallographic analyses. Importantly, DnaJb5 likely plays an impor-990 Cell 133, 978–993, June 13, 2008 ª2008 Elsevier Inc.tant role in bringing Trx1 and HDAC4 into close proximity, so that
Trx1 is able to reduce HDAC4 efficiently.
Molecular Structure and Activity of HDAC4
The redox states of Cys-667 and Cys-669 in the HDAC domain
are not involved in the interaction with DnaJb5 but play an impor-
tant role in regulating the localization of HDAC4. This implies
a scenario in which oxidized HDAC4 is recognized by DnaJb5,
reduced by Trx1 which associates with DnaJb5, and reimported
into the nucleus (Figure 6K).
On the other hand, Cys-813, located in the catalytic core, is not
oxidized even after treatment with a high concentration of H2O2.
In addition, the C667/669S substitution did not significantly af-
fect the catalytic activity of HDAC4, at least as measured by tran-
scriptional repression of GAL4-luciferase activity (Figure S10).
Thus, the redox regulation may not affect the catalytic activity
of HDAC4.
Significance of the Substitution of Redox-Sensitive
Cysteine to Serine in DnaJb5 and HDAC4
In general, substitution of a redox-sensitive cysteine to serine in
a protein mimics its reduced form because serine is structurally
similar to the reduced from of cysteine and it can no longer be
oxidized. However, the serine substitution could abolish the
function of the molecule when cysteines are catalytically impor-
tant or mediate coordination of metal, such as zinc, thereby
acting similarly to the oxidized form. We speculate that the
Cys-to-Ser mutants in DnaJb5 and HDAC4 functionally mimic
their oxidized forms, because both the Cys-to-Ser mutations
and disulfide bond formation would disrupt the zinc coordination
and interaction with HDAC4 and NES, respectively.
Redox- versus Phosphorylation-Mediated
Regulation of Class II HDACs
Hypertrophic stimuli induce phosphorylation of serine residues
in class II HDACs, thereby leading to nuclear export of the
HDACs (Backs and Olson, 2006; McKinsey et al., 2000). We pro-
pose here that redox-mediated regulation is another important
mechanism determining the subcellular localization of class II
HDACs. Hypertrophic stimuli are often accompanied by in-
creased production of ROS, which could cause thiol oxidation
of cysteines (Berndt et al., 2007). Thus, oxidation and phosphor-
ylation of HDAC4 can both take place during hypertrophic
responses. Because Trx1 did not affect PE-induced phosphory-
lation of HDAC4, it is unlikely that Trx1 regulates the activity of
upstream kinases of class II HDACs. Indeed, Trx1 failed to inhibit(G) Protein levels of HDAC4 in the nucleus or cytosol in NTg or Tg-HDAC4 C667/669S mouse hearts were determined by immunoblot. The
percentage to total HDAC4 protein in each compartment was analyzed by densitometric analyses.
(H) The effect of the C667/669S substitution in HDAC4 on the interaction with DnaJb5 was examined by pull-down assays.
(I) Interaction of DnaJb5 with either wild-type HDAC4 or the C667/669S mutant was examined by coimmunoprecipitation with lysates of myocytes overexpress-
ing either wild-type or mutant HDAC4. Immunoblots of control lysates are also shown.
(J) The indicated GST proteins were incubated with MBP-HDAC4 NES (1040-1084) for pull-down assays (left). Interaction was detected by immunoblot with an
anti-MBP antibody. Effects of zinc, EDTA, and H2O2 on the interaction between the HDAC domain and the NES were examined by pull-down assays (right).
(K) A scheme for redox regulation of HDAC4 by Trx1. HDAC4 suppresses positive mediators of cardiac hypertrophy, such as NFAT, in the nucleus when in a re-
duced state. During oxidative stress, HDAC4 is promptly oxidized and exported to the cytosol, where it can no longer suppress positive mediators of hypertro-
phy. Reduced DnaJb5, upregulated by Trx1, interacts with HDAC4. Trx1 reduces critical cysteines in HDAC4 by forming a multiprotein complex including
DnaJb5, TBP-2, and importin a (Imp), thereby returning HDAC4 to the nucleus.
Figure 7. Redox- versus Phosphorylation-Mediated Regulation of Class II HDACs
(A) Myocytes transduced with the indicated adenoviruses were stained with an HDAC4 antibody (green), an actinin antibody (red), and DAPI (blue). As indicated,
myocytes were treated with PE for 4 hr.
(B) Effects of the indicated vectors on NFAT activity were determined by NFAT-reporter gene assays in myocytes. Error bars indicate standard errors (n = 9,
*p < 0.05).
(C) Cell surface area was measured in myocytes treated with the indicated adenoviruses. Surface area of myocytes transduced with LacZ was arbitrarily set to
100%. Error bars indicate standard errors (n = 6, *p < 0.05).
(D) Five days after injection of the indicated HA-tagged adenoviruses, specimens of rat hearts were stained with an HA antibody with the use of a horseradish-
peroxidase system.
(E) ANF- and renilla-luciferase vectors and the indicated pcDNA vectors were injected into rat hearts. Five days after injection, heart homogenates were prepared
from the injected area, and dual luciferase assays were performed. Error bars indicate standard errors (n = 4, *p < 0.05).Cell 133, 978–993, June 13, 2008 ª2008 Elsevier Inc. 991
PE-induced activation of CaMK and PKD (Figure S11), well-
known upstream kinases of class II HDACs (Backs and Olson,
2006). Importantly, oxidation of Cys-667 and Cys-669 and
nuclear export of HDAC4 occur more rapidly than phosphoryla-
tion after hypertrophic stimulation. These findings suggest that
nuclear export of HDAC4 may be biphasic, with redox regulation
mediating the early phase of nuclear export. On the other hand,
phosphorylation may be needed for a later phase of nuclear
export or for maintaining the cytosolic localization of HDAC4
after redox-mediated export. Some of our data also suggest
that redox-mediated regulation could override the phosphoryla-
tion-mediated one. Thus, targeting redox regulation of HDAC4
could be an independent modality of treatment for cardiac
hypertrophy.
In conclusion, we demonstrate a novel mechanism controlling
cardiac muscle growth. Both hypertrophic stimuli and Trx1 affect
the redox status of the conserved cysteine residues in class II
HDACs, which in turn regulates the nucleocytoplasmic localiza-
tion of class II HDACs and the activity of hypertrophy master key
genes, such as NFAT, in cardiac myocytes.
EXPERIMENTAL PROCEDURES
Transgenic Mice
All of the transgenic mice used in this study were generated on an FVB back-
ground with the a myosin heavy chain promoter. All protocols concerning
animal use were approved by the Institutional Animal Care and Use Committee
at the University of Medicine and Dentistry of New Jersey.
Recombinant Proteins and Pull-Down Binding Assays
Proteins fused to glutathione S-transferase (GST) or to maltose binding protein
(MBP) were expressed in E. coli strain BL21 (DE3) and purified with glutathione
Sepharose 4B (Amersham Biosciences) or amylose resin (New England
Biolabs).
Immunoblot Analyses
Heart homogenates and cardiac myocyte lysates were prepared in RIPA lysis
buffer containing 50 mM Tris (pH 7.5), 150 mM NaCl, 1% IGEPAL CA-630,
0.1% SDS, 0.5% deoxycholic acid, 10 mM Na4P2O7, 5 mM EDTA, 0.1 mM
Na3VO4, 1 mM NaF, 0.5 mM 4-(2-Aminoethyl) benzenesulfonyl fluoride hydro-
chloride (AEBSF), 0.5 mg/ml aprotinin, and 0.5 mg/ml leupeptin. The nuclear
and cytosolic fractions from myocytes and mouse hearts were prepared
with NE-PER Nuclear and Cytoplasmic Extraction Reagents (PIERCE).
Immunoprecipitation
Antibodies used for immunoprecipitation (IP) were immobilized to protein A
agarose (Santa Cruz) with 50 mM dimethyl pimelimidate (PIERCE) before
use. After lysis of myocytes with the RIPA buffer, lysates were incubated
with the antibody-immobilized to protein A agarose for 1 hr. After IP products
were washed with RIPA buffer three times, they were eluted with 23 sample
buffer.
Luciferase Assay
Transfection of plasmids into myocytes was performed with Fugene 6 (Roche).
Luciferase activity was measured with a luciferase assay system (Promega).
The method of in vivo reporter gene assays has been described (Morisco
et al., 2001). In brief, 20 mg ANF- and 1 mg renilla-luciferase vectors together
with the indicated vectors (1 mg) suspended in 150 ml 0.9% saline were injected
into the LV wall. Five days after injection, homogenates were prepared from the
injected area with Reporter Lysis Buffer (Promega).992 Cell 133, 978–993, June 13, 2008 ª2008 Elsevier Inc.Trx1 Reduction Assay
The activity of Trx1 was detected as a reduction in absorbance at 340 nm,
indicating oxidation of NADPH as previously described (Yamamoto et al.,
2003). We used recombinant Trx1 or cell lysates.
Mass Spectrometry
Purified GST-DnaJb5 and GST-HDAC domain of HDAC4 were treated with tris
(2-carboxyethyl)phosphine (TCEP) or 250 mM H2O2 for 10 min at room temper-
ature. For cell samples, lysates of myocytes overexpressing HA-DnaJb5 were
subjected to IP with a sarcomeric actin (Sigma). Supernatants were further
subjected to IP with HA-agarose (Sigma), and eluates were separated by
SDS-PAGE. After staining with coomassie brilliant blue (CBB), HA-DnaJb5
was extracted from the gel. The samples were digested with trypsin or Glu-
C and desalted with C18 ZipTip (Millipore Corporation) and analyzed on
a 4700 Proteomics Analyzer tandem mass spectrometer (Applied Biosystems
[ABI]). Positive ion mass spectra were acquired in the reflectron mode. Tan-
dem mass spectra of selected ions were acquired with a method optimized
with 1 KV collision energy. Data analysis was performed with Data Explorer
software (ABI).
Detection of Thiolate Cysteines
Myocytes transduced with DnaJb5 or HDAC4 adenoviruses were treated with
PE in the presence or absence of Trx1 overexpression for the indicated time
periods and lysed with lysis buffer containing 200 mM biotinylated-IAM (Molec-
ular Imaging Product Company). Biotinylated proteins were pulled down on
streptavidin beads (PIERCE).
Statistical Analysis
All values are expressed as mean ± SEM. Statistical analyses between groups
were done by unpaired Student’s t test or one-way ANOVA followed by a post
hoc Fisher’s comparison test. A value of p < 0.05 was accepted as significant.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures, eleven
figures, and Supplemental References and can be found with this article online
at http://www.cell.com/cgi/content/full/133/6/978/DC1/.
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